Vaccine against erysipelas of pigs from strain BP-2 live dry (100 doses) 5 ml
DESCRIPTION
Live dry vaccine against swine erysipelas from strain BP-2. In appearance, the vaccine is a dry, porous or crystalline mass from light beige to light brown. When the vaccine is diluted within 1-3 minutes, a homogeneous suspension is formed.
COMPOSITION
The vaccine is made from the attenuated vaccine strain Erysipelothrix rhusiopathiae BP-2 with the addition of 25% sucrose-peptone-gelatin stabilizer (live vaccine).
BIOLOGICAL PROPERTIES
Pharmacotherapeutic group: Immunobiological drug.
The vaccine causes the formation of an immune response to the causative agent of erysipelas in young pigs on the 5-8th day after a double, and in pigs older than 4 months of age - a single injection, lasting 5 months.
One immunizing dose contains 200 million live microbial cells of the vaccine strain culture.
The vaccine is harmless and has no medicinal properties.
DOSAGE AND APPLICATION
The vaccine is intended for prophylactic immunization of pigs against erysipelas.
Vaccination is carried out in compliance with the rules of asepsis and antiseptics.
Before use, the vaccine is diluted with 0.85% saline at the rate of 1 cm3 per one immunizing dose. The diluted vaccine must be used within 4 hours. The injection site is disinfected with a 70% ethyl alcohol solution.
Piglets are vaccinated starting from 2 months of age twice with an interval of 25-30 days; pigs older than 4 months - once. Revaccinate animals every 5 months at the same dose.
Pregnant sows are vaccinated 30-35 days before farrowing.
The vaccine is administered intramuscularly behind the ear or in the area of ​​the inner surface of the thigh at a dose of 200 million live microbial cells in a volume of 1 cm3, regardless of the age and weight of the animals.
In case of swine erysipelas, all clinically healthy animals on the farm are vaccinated regardless of the timing of the previous vaccine administration.
Sick pigs are isolated and treated with antiporotic serum and antibiotics of the penicillin series, animals after treatment are vaccinated no earlier than 14 days later.
SPECIAL INSTRUCTIONS
Symptoms of erysipelas or other pathological signs in case of an overdose of the vaccine have not been established.
The features of the manifestation of the post-vaccination reaction during the initial and subsequent vaccine injections have not been established.
The peculiarities of the use of the vaccine during pregnancy and lactation of sows were not revealed.
Violation of the vaccination schedule should be avoided, as this can lead to a decrease in the effectiveness of immunoprophylaxis in swine erysipelas. If the next vaccine is missed, immunization should be carried out as soon as possible.
CONTRAINDICATIONS
It is forbidden to vaccinate animals that are clinically sick and / or weakened.
It is prohibited to use antibiotics for 14 days before and after vaccination.
SIDE EFFECTS
In vaccinated animals, the body temperature may rise to 40.5 В° C and the manifestation of signs of depression, as a rule, spontaneously disappear within 2 days.
SHELF LIFE AND STORAGE
The shelf life of the vaccine is 12 months from the date of issue, subject to the storage and transportation conditions. After the expiration date, the vaccine is not suitable for use.
The vaccine is stored and transported in a dry, dark place at a temperature of 2 В° C to 8 В° C.
PACKAGING
The vaccine is packaged in 5 ml vials (from 50 to 120 doses). The number of doses in vials is determined after the final control. Vials are hermetically sealed with rubber stoppers, reinforced with aluminum caps.
Specifications
KolVUP
25
Manufacturer
Shchelkovo Biocombine
Temperature regime
from +2 to +8
Teaser
live dry vaccine against swine erysipelas from strain BP-2